Navigation Links
StemGenex to Launch Adult Stem Cell-Based Therapy to Relieve COPD Symptoms

LA JOLLA, Calif., Sept. 20, 2012 /PRNewswire/ -- New developments in regenerative medicine are bringing about exciting, novel approaches to create therapies for hard to treat diseases. Chronic obstructive pulmonary disease (COPD) is a hard to treat disorder that progressively blocks airflow in the lungs making it increasingly difficult for an individual to breathe, and is one of the leading illnesses in the US. Yet, current treatments for COPD can only try to limit the extent of damage to the lungs, and to bring some relief from symptoms. Novel treatments for COPD are urgently needed, and new applications with the use of adult stem cells may have much benefit. This is because adult stem cells have an ability to differentiate into many different types of cells, such as those required for healthy, functioning lung tissue. Also, adult stem cells can be isolated with ease from an individual's own fat tissue, and so adult stem cell therapy is not subject to the ethical or religious issues that trouble some other methods.


StemGenex, a US based company, is finding new avenues and methods for using adipose derived adult stem cells to help in diseases with limited treatment options. StemGenex has been working with scientists and physicians over the last 5 years to specifically advance adult stem cell treatment protocols, and the hope is that COPD adult stem cell therapy can help in alleviating COPD symptoms. Results from researchers working with adult stem cells have shown anti-inflammatory and immune modulatory effects, suggesting possible roles in treating COPD. Interestingly, recent studies in mice indicate the presence of stem cells in the lungs can regenerate damaged lung tissue which occurs through infection. Encouragingly, adult stem cell treatment studies in mice appear to have positive effects across a range of respiratory diseases, which includes COPD.

Taking these research findings into account and building on their own developments, StemGenex is about to submit a plan of using adult stem cell therapy for COPD treatment to an Institutional Review Board for review. This study could scientifically define any potential benefits of such clinical treatments. Rita Alexander, the President of StemGenex, says, "Chuck Liptak, a long-term COPD sufferer, eliminated his requirement for oxygen following a stem cell treatment.  It's imperative that these results be scientifically quantified."  

To find out more about stem cell treatments contact StemGenex. An experienced stem cell physician reviews the patient evaluation and a patient can have any questions or requests for more detailed information addressed by a patient advocate. StemGenex™ is based in La Jolla, California with treatment locations on the east and west coast.

La Jolla Cove Research Center
505 Coast Boulevard South
La Jolla, CA 92037
858-459-STEM (7836)

SOURCE StemGenex
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
2. iBioLaunch™ Technology Successfully Applied to Modified C1 Inhibitor
3. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
4. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
9. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
10. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
(Date:10/13/2015)... ... 2015 , ... The Pistoia Alliance has appointed Dr Steve ... drive to increase the organization’s impact on the global innovation landscape in life ... its work in supporting pre-competitive collaboration in the life sciences sector. Steve brings ...
(Date:10/13/2015)... Applied BioMath ( ), a computational ... the drug invention process, announced that it will sponsor ... 20-22, 2015 in Boston , MA.  ... CEO of Applied BioMath, will present "QSP approaches enabling quantitative ... trials" on Wednesday October 21st 2015 at 12:30PM.  ...
(Date:10/13/2015)... ARRY ), Avanex Life Sciences ... ), and Progenix Pharmaceuticals, Inc. (NASDAQ: PGNX ) ... (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), ... --> Cooperative research and development efforts with the ... to advancements in the treatment of severe wounds.  Biotech ...
(Date:10/13/2015)... and SAN DIEGO , ... Mast Therapeutics, Inc. have agreed to collaborate in the ... poloxamer 188 NF, marketed by BASF under the Kolliphor ... a variety of pharmaceutical and biological applications, such as ... is the starting material for Mast,s lead product candidate. ...
Breaking Biology Technology:
(Date:10/2/2015)... 2015 ) ... the Law Using Biometrics" report to their ... the addition of the "Enforcing the Law ... --> Research and Markets ( ) ... the Law Using Biometrics" report to their ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
Breaking Biology News(10 mins):